PT  - JOURNAL ARTICLE
AU  - Hafez, Mohamed M
AU  - Hassan, Zeinab K
AU  - Bahnasy, Abeer A.
AU  - Ahmed, Ola S.
AU  - Abouelhoda, Mohamed
AU  - Zekri, Abdel-Rahman N.
TI  - SARS-CoV-2 receptor mutation in Egyptian population
AID  - 10.1101/2020.04.27.20082206
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.27.20082206
4099  - http://medrxiv.org/content/early/2020/05/02/2020.04.27.20082206.short
4100  - http://medrxiv.org/content/early/2020/05/02/2020.04.27.20082206.full
AB  - The Coronavirus disease 2019 (COVID-19) is a respiratory tract infectious disease caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 triggers severe pneumonia leading to acute respiratory distress syndrome and death in severe cases. According to WHO reported, Egypt is among the countries with low confirmed SARS CoV2 infected symptomatic cases and death. We postulate that one of the reasons for this may be due mutations in the viral receptor. Therefore this study was conducted to confirm or reject this postulation.Competing Interest StatementThe authors have declared no competing interest.Funding Statementwork was supported by STDF grant.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary file attached.